174 related articles for article (PubMed ID: 24302553)
1. Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer.
Wang Q; Liu H; Xiong H; Liu Z; Wang LE; Qian J; Muddasani R; Lu V; Tan D; Ajani JA; Wei Q
Mol Carcinog; 2015 Jun; 54(6):449-58. PubMed ID: 24302553
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase gene predict risk and survival in gastric cancer.
Shen R; Liu H; Wen J; Liu Z; Wang LE; Wang Q; Tan D; Ajani JA; Wei Q
Mol Carcinog; 2015 Sep; 54(9):880-8. PubMed ID: 24756984
[TBL] [Abstract][Full Text] [Related]
3. A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression.
Cheng M; Yang L; Yang R; Yang X; Deng J; Yu B; Huang D; Zhang S; Wang H; Qiu F; Zhou Y; Lu J
Carcinogenesis; 2013 Oct; 34(10):2292-9. PubMed ID: 23715500
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population.
Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
Lung; 2016 Jun; 194(3):393-400. PubMed ID: 27130457
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the stem cell marker gene
Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
BMJ Open; 2017 Aug; 7(8):e016913. PubMed ID: 28827262
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.
Jia ZF; Wu YH; Cao DH; Cao XY; Jiang J; Zhou BS
Future Oncol; 2017 May; 13(11):979-989. PubMed ID: 28326835
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of microRNA target genes
Petkevicius V; Salteniene V; Juzenas S; Wex T; Link A; Leja M; Steponaitiene R; Skieceviciene J; Kupcinskas L; Jonaitis L; Kiudelis G; Malfertheiner P; Kupcinskas J
World J Gastroenterol; 2017 May; 23(19):3480-3487. PubMed ID: 28596683
[TBL] [Abstract][Full Text] [Related]
8. Effect of CD133 polymorphisms on the risk of developing liver cirrhosis and hepatocellular carcinoma induced by viral hepatitis.
Hassan M; Nasr SM; Elzallat M
Virus Res; 2022 Apr; 312():198714. PubMed ID: 35181408
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
[TBL] [Abstract][Full Text] [Related]
10. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
[TBL] [Abstract][Full Text] [Related]
11. A genetic variant of miR-148a binding site in the SCRN1 3'-UTR is associated with susceptibility and prognosis of gastric cancer.
Song P; Zhu H; Zhang D; Chu H; Wu D; Kang M; Wang M; Gong W; Zhou J; Zhang Z; Zhao Q
Sci Rep; 2014 Nov; 4():7080. PubMed ID: 25399950
[TBL] [Abstract][Full Text] [Related]
12. Association of
Wang XQ; Terry PD; Li Y; Zhang Y; Kou WJ; Wang MX
World J Gastroenterol; 2019 Sep; 25(34):5152-5161. PubMed ID: 31558863
[TBL] [Abstract][Full Text] [Related]
13. Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development.
Mesic A; Rogar M; Hudler P; Bilalovic N; Eminovic I; Komel R
BMC Cancer; 2019 Sep; 19(1):919. PubMed ID: 31521144
[TBL] [Abstract][Full Text] [Related]
14. Associations of Functional MicroRNA Binding Site Polymorphisms in IL23/Th17 Inflammatory Pathway Genes with Gastric Cancer Risk.
Dong K; Xu Y; Yang Q; Shi J; Jiang J; Chen Y; Song C; Wang K
Mediators Inflamm; 2017; 2017():6974696. PubMed ID: 29118466
[TBL] [Abstract][Full Text] [Related]
15. Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population.
Ahn DH; Rah H; Choi YK; Jeon YJ; Min KT; Kwack K; Hong SP; Hwang SG; Kim NK
Mol Carcinog; 2013 Nov; 52 Suppl 1():E39-51. PubMed ID: 23001871
[TBL] [Abstract][Full Text] [Related]
16. The miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer.
Xu Y; Ma H; Yu H; Liu Z; Wang LE; Tan D; Muddasani R; Lu V; Ajani JA; Wang Y; Wei Q
PLoS One; 2013; 8(5):e64973. PubMed ID: 23724109
[TBL] [Abstract][Full Text] [Related]
17. CD24 genetic variants contribute to overall survival in patients with gastric cancer.
Jia ZF; Wang LZ; Cao XY; Wang C; Cao DH; Wu X; You LL; Jin MS; Wang YP; Zhou BS; Jiang J
World J Gastroenterol; 2016 Feb; 22(7):2373-82. PubMed ID: 26900300
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer.
Kashfi SM; Behboudi Farahbakhsh F; Nazemalhosseini Mojarad E; Mashayekhi K; Azimzadeh P; Romani S; Derakhshani S; Malekpour H; Asadzadeh Aghdaei H; Zali MR
Tumour Biol; 2016 Feb; 37(2):2119-26. PubMed ID: 26346169
[TBL] [Abstract][Full Text] [Related]
19. Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population.
Yang C; Tang R; Ma X; Wang Y; Luo D; Xu Z; Zhu Y; Yang L
Oncotarget; 2015 Jun; 6(17):15311-20. PubMed ID: 25944697
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
